Causes and Outcomes of Community Acquired Pneumonia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-02-28

Study Completion Date

2014-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a descriptive clinical research aiming:

* To describe the clinical spectrum and clinical characteristics of community acquired pneumonia (CAP) in patients admitted to hospital
* To identify the etiology of CAP and the antibiotic sensitivity of the isolated organisms
* To identify the risk factors that influence the severity of CAP

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Characteristics and Outcome of Patients With Community Acquired Pneumonia

NCT06716099

Community Acquired Pneumonia (CAP)

NOT_YET_RECRUITING

A Molecular Toolkit for the Microbial Investigation of Severe Community Acquired Pneumonia

NCT02963142

Community Acquired Pneumonia Respiration Failure Pneumonia

COMPLETED

Etiology of Community Acquired Pneumonia

NCT00471757

Streptococcus Pneumonia Haemophilus Influencae Mycoplasma Pneumonia +1 more

COMPLETED

Predictors of Improvement and Deterioration of Community Acquired Pneumonia in Children

NCT06720441

Predictors of Improvement and Deterioration of Community Acquired Pneumonia

NOT_YET_RECRUITING

Microbiology and Clinical Outcome of Pneumonia

NCT00873522

Pneumonia

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In Vietnam, the range and relative contribution of organisms causing CAP remain unclear, largely because diagnostic tools are limited and clinical research uncommon. An improved understanding of the risk factors, etiology and clinical outcomes of CAP in Vietnam would contribute to improved approaches to patient diagnosis and clinical management. This will be achieved by following the clinical and laboratory progress and treatment outcomes of in-patients diagnosed with CAP from admission to discharge. Comparative analyses will be between subgroups including survivor and non-survivor, severe CAP and non-severe CAP, known etiology and unknown etiology, SIRS, sepsis, severe sepsis and shock septic.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Community Acquired Pneumonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients \> or = 18 years of age
* Patient meets the criteria of pneumonia (below), established within 36h of hospitalization
* Patient is not hospitalized or residing in a long-term-care facility within 14 days before the onset of symptoms
* Patient has not been at a referral hospital for \>2 days before admission to the study hospital
* Informed consent to participate in the study is provided

Exclusion Criteria

* Severe immunosuppression as judged by the enrolling physician (e.g. HIV, leukemia, lymphoma, chemotherapy for solid tumors, long-term corticosteroid use or other immunosuppressive drugs)
* Known active tuberculosis or current treatment for tuberculosis

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No